Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Spero Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    SPERO THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Spero Therapeutics
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    675 Massachusetts Avenue 14th Floor Cambridge, MA 02139
    Telephone
    Telephone
    + 857-242-1600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sperotherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/spero-therapeutics/?originalSubdomain=in
    Twitter
    Twitter
    https://twitter.com/spero_tx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results
    Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results

    https://www.globenewswire.com//news-release/2024/03/13/2845822/0/en/Spero-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2023-Operating-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    13 Mar 2024
    Share Share
    Spero Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
    Spero Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

    https://www.globenewswire.com//news-release/2024/03/06/2841401/0/en/Spero-Therapeutics-to-Provide-Business-Update-and-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-Wednesday-March-13-2024.html

    GLOBENEWSWIRE
    06 Mar 2024
    Share Share
    Spero Therapeutics Announces Clearance of IND for SPR206
    Spero Therapeutics Announces Clearance of IND for SPR206

    https://www.globenewswire.com//news-release/2024/02/28/2836936/0/en/Spero-Therapeutics-Announces-Clearance-of-IND-for-SPR206-to-Treat-MDR-Gram-negative-Bacterial-Infections.html

    GLOBENEWSWIRE
    28 Feb 2024
    Share Share
    Spero Therapeutics to Present at Cowen™s 44th Annual Healthcare Conference
    Spero Therapeutics to Present at Cowen™s 44th Annual Healthcare Conference

    https://www.globenewswire.com//news-release/2024/02/26/2835109/0/en/Spero-Therapeutics-to-Present-at-Cowen-s-44th-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    26 Feb 2024
    Share Share
    Spero Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    Spero Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    https://www.globenewswire.com/news-release/2024/01/31/2821549/0/en/Spero-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    31 Jan 2024
    Share Share
    Spero Therapeutics Provides Corporate Update and 2024 Outlook
    Spero Therapeutics Provides Corporate Update and 2024 Outlook

    https://www.globenewswire.com//news-release/2024/01/05/2804625/0/en/Spero-Therapeutics-Provides-Corporate-Update-and-2024-Outlook.html

    GLOBENEWSWIRE
    05 Jan 2024
    Share Share
    Spero Announces First Patient, First Visit for Ph 3 Trial Evaluating Tebipenem
    Spero Announces First Patient, First Visit for Ph 3 Trial Evaluating Tebipenem

    https://www.globenewswire.com//news-release/2024/01/02/2802657/0/en/Spero-Therapeutics-Announces-First-Patient-First-Visit-for-Phase-3-PIVOT-PO-Trial-Evaluating-Tebipenem-HBr-in-Complicated-Urinary-Tract-Infections.html

    GLOBENEWSWIRE
    02 Jan 2024
    Share Share
    Spero Therapeutics Announces Third Quarter 2023 Operating Results
    Spero Therapeutics Announces Third Quarter 2023 Operating Results

    https://www.globenewswire.com//news-release/2023/11/13/2779452/0/en/Spero-Therapeutics-Announces-Third-Quarter-2023-Operating-Results-and-Provides-a-Business-Update.html

    GLOBENEWSWIRE
    13 Nov 2023
    Share Share
    Spero Therapeutics to Report Third Quarter 2023 Financial Results
    Spero Therapeutics to Report Third Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2023/11/06/2774092/0/en/Spero-Therapeutics-to-Provide-Business-Update-and-Report-Third-Quarter-2023-Financial-Results-on-Monday-November-13-2023.html

    GLOBENEWSWIRE
    06 Nov 2023
    Share Share
    Spero Therapeutics to Present at Upcoming November Investor Conferences
    Spero Therapeutics to Present at Upcoming November Investor Conferences

    https://www.globenewswire.com//news-release/2023/11/01/2771695/0/en/Spero-Therapeutics-to-Present-at-Upcoming-November-Investor-Conferences.html

    GLOBENEWSWIRE
    01 Nov 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search